Asthma and Allergic Diseases Cooperative Research Centers

The summary for the Asthma and Allergic Diseases Cooperative Research Centers grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Asthma and Allergic Diseases Cooperative Research Centers: - The National Institute of Allergy and Infectious Diseases (NIAID) invites applications from single institutions and consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The purpose of this RFA is to support basic and clinical research on the immunological basis, pathobiology, diagnosis, treatment and prevention of asthma and allergic diseases and to accelerate the application of fundamental knowledge of immune function to the investigation, prevention, and treatment of asthma and allergic diseases. - In FY 2006, NIAID anticipates awarding a total of $11 million to support the Centers. Additional discretionary funds of $1 million per year will be provided to support new projects on emerging opportunities. - Seven to ten new awards are anticipated. - This initiative will be funded using the multi-project Cooperative Agreement (U19) award mechanism. - A minimum of two research projects must be proposed. At least one of the projects must focus on immunologic aspects of asthma and/or allergic diseases in humans, and must be qualified as clinical research as defined in NIH grant guidance and policy ( - An institution may submit only one application; however, applications may include investigators from more than one institution if such arrangements enhance the scientific strength of the proposed research program. In addition, a Principal Investigator may serve as a Project Leader in a multi-project application if there is no scientific overlap with the application submitted by the Principal Investigator. - Eligible organizations include: domestic for-profit and non-profit organizations; public and private institutions, such as universities, colleges, hospitals, laboratories, units of State and local governments, and eligible agencies of the Federal government. Foreign institutions are not eligible to apply as the primary applicant but may enter into a consortium with a domestic institution serving as the primary applicant. - Eligible Principal Investigators include all individuals with the skills, knowledge, and resources necessary to carry out the proposed research. Racial/ethnic minority individuals, women, and persons with disabilities are encouraged to apply as Principal Investigators. - The PHS 398 document is available at For further assistance contact Grantsinfo, Telephone (301)435-0714, Email: [email protected]. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088.
Federal Grant Title: Asthma and Allergic Diseases Cooperative Research Centers
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-05-027
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.855
CFDA Descriptions: Allergy, Immunology and Transplantation Research
Current Application Deadline: No deadline provided
Original Application Deadline: Oct 12, 2005
Posted Date: May 25, 2005
Creation Date: May 25, 2005
Archive Date: Nov 11, 2005
Total Program Funding: $11,000,000
Maximum Federal Grant Award: $1,000,000
Minimum Federal Grant Award:
Expected Number of Awards: 7
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are not eligible to apply as the primary applicant but may enter into a consortium with the domestic institution as the primary applicant.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Anti...
Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
Center for HIV/AIDS Vaccine Immunology (CHAVI)
Genomics of Transplantation Cooperative Research Program
Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R0...
More Grants from the National Institutes of Health
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required...
NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 -...
HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed)
Single Source: NINDS Exploratory Clinical Trials (U01 Clinical Trial Required)
Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024